• Explore /
  • Poster
  • / Randomized phase III study of adjuvant chemotherapy for node-positive early breast cancer (BC) patients (pts) comparing epirubicin plus cyclophosphamide followed by docetaxel (EC-T) versus epirubicin plus docetaxel followed by capecitabine (ET-X): Efficacy analysis of the GEICAM/2003-10 trial.

Randomized phase III study of adjuvant chemotherapy for node-positive early breast cancer (BC) patients (pts) comparing epirubicin plus cyclophosphamide followed by docetaxel (EC-T) versus epirubicin plus docetaxel followed by capecitabine (ET-X): Efficacy analysis of the GEICAM/2003-10 trial.

Abstract Poster

Authors

null

Begoña Bermejo

Hospital Clinico Universitario Valencia, Valencia, Spain

Begoña Bermejo , Amparo Ruiz , Manuel Ruiz Borrego , Nuria Ribelles , Alvaro Rodriguez-Lescure , Montserrat Munoz-Mateu , Sonia Gonzalez , Mireia Margeli , Agust Barnadas , Manuel Ramos Vazquez , Sonia del Barco , Lourdes Calvo , Cesar Mendiola , Carmen Crespo , Cesar Augusto Rodriguez , Eduardo Martinez , Maria Isabel Casas , M Carmen Camara , Eva Maria Carrasco , Miguel Martin

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Breast Cancer - Triple-Negative/Cytotoxics/Local Therapy

Track

Breast Cancer

Sub Track

Cytotoxic Chemotherapy

Clinical Trial Registration Number

NCT00129935

Citation

J Clin Oncol 31, 2013 (suppl; abstr 1027)

DOI

10.1200/jco.2013.31.15_suppl.1027

Abstract #

1027

Poster Bd #

19

Abstract Disclosures

Similar Posters

First Author: Volker Moebus

First Author: Alexios Matikas

First Author: Justin Stebbing

First Author: Volker Jochen Moebus